Extract

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of teduglutide compared with placebo in subjects with parenteral nutrition (PN)-dependent short bowel syndrome (SBS).

Inclusion criteria

• Short Bowel Syndrome

Country

• Belgium
• Canada
• Denmark
• France
• Germany
• Netherlands
• Poland
• United Kingdom
• United States

Links

• ictrp
• nct